Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Medicare covers TriClip | First patient receives new heart pump | Cardiology still an AI leader | Myval TAVR valve after 4 years

News You Need to Know Today
Medicare covers TriClip | First patient receives new heart pump | Cardiology still an AI leader | Myval TAVR valve after 4 years
Friday, July 11, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation

CMS has finalized a new national coverage determination for T-TEER, sometimes known as transcatheter tricuspid valve repair. Abbott's TriClip is the only device approved by the FDA for T-TEER, but other treatment options are under development.

READ MORE >
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
Share on Twitter Share on Facebook Share on Linkedin

Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation

Share on Twitter Share on Facebook Share on Linkedin
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
CMS has finalized a new national coverage determination for T-TEER, sometimes known as transcatheter tricuspid valve repair. Abbott's TriClip is the only device approved by the FDA for T-TEER, but other treatment options are under development.
READ MORE >

World’s first patient receives new-look heart pump—cardiologist ‘impressed’ by device’s performance

The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 

READ MORE >
CorWave LVAD
Share on Twitter Share on Facebook Share on Linkedin

World’s first patient receives new-look heart pump—cardiologist ‘impressed’ by device’s performance

Share on Twitter Share on Facebook Share on Linkedin
CorWave LVAD
The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 
READ MORE >

Cardiology still No. 2 in FDA-cleared clinical AI algorithms, trailing only radiology

Cardiology continues to be one of the most influential healthcare specialties when it comes to utilizing artificial intelligence. 

READ MORE >
An example of artificial intelligence automated coronary artery calcium scoring shown by Coreline at ACC23. The AI also identifies and color codes the anatomy so help show the reviewing radiologist or cardiac imager what and where things were calculated. #ACC #ACC23
Share on Twitter Share on Facebook Share on Linkedin

Cardiology still No. 2 in FDA-cleared clinical AI algorithms, trailing only radiology

Share on Twitter Share on Facebook Share on Linkedin
An example of artificial intelligence automated coronary artery calcium scoring shown by Coreline at ACC23. The AI also identifies and color codes the anatomy so help show the reviewing radiologist or cardiac imager what and where things were calculated. #ACC #ACC23
Cardiology continues to be one of the most influential healthcare specialties when it comes to utilizing artificial intelligence. 
READ MORE >

Myval TAVR valve associated with positive durability data after 4 years

Researchers have been spending more and more time evaluating the Myval TAVR valve from Indian medtech company Meril Life Sciences. The balloon-expandable device is available in some parts of the world, but not the United States.

READ MORE >
The balloon-expandable Myval transcatheter aortic valve replacement (TAVR) valve is associated with positive real-world data after four years.
Share on Twitter Share on Facebook Share on Linkedin

Myval TAVR valve associated with positive durability data after 4 years

Share on Twitter Share on Facebook Share on Linkedin
The balloon-expandable Myval transcatheter aortic valve replacement (TAVR) valve is associated with positive real-world data after four years.
Researchers have been spending more and more time evaluating the Myval TAVR valve from Indian medtech company Meril Life Sciences. The balloon-expandable device is available in some parts of the world, but not the United States.
READ MORE >

Featured Articles

Statin use may protect patients from subarachnoid hemorrhages

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

READ MORE >
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Share on Twitter Share on Facebook Share on Linkedin

Statin use may protect patients from subarachnoid hemorrhages

Share on Twitter Share on Facebook Share on Linkedin
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.
READ MORE >

‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor

The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.

READ MORE >
aktiia hilo band cuffless blood pressure monitor
Share on Twitter Share on Facebook Share on Linkedin

‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor

Share on Twitter Share on Facebook Share on Linkedin
aktiia hilo band cuffless blood pressure monitor
The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.
READ MORE >

Early occlusion after CABG much more likely for female patients

Care teams should be aware of this difference, even using CT images when possible to look for signs of any potential issues.

READ MORE >
old woman or doctor shaking hands with patient
Share on Twitter Share on Facebook Share on Linkedin

Early occlusion after CABG much more likely for female patients

Share on Twitter Share on Facebook Share on Linkedin
old woman or doctor shaking hands with patient
Care teams should be aware of this difference, even using CT images when possible to look for signs of any potential issues.
READ MORE >

In Case You Missed It

Surgeons complete first fully robotic heart transplant in US history

The historic procedure was performed in Texas on a 45-year-old patient who had been hospitalized for months with advanced heart failure.

READ MORE >
heart surgery Baylor St. Luke's Medical Center
Share on Twitter Share on Facebook Share on Linkedin

Surgeons complete first fully robotic heart transplant in US history

Share on Twitter Share on Facebook Share on Linkedin
heart surgery Baylor St. Luke's Medical Center
The historic procedure was performed in Texas on a 45-year-old patient who had been hospitalized for months with advanced heart failure.
READ MORE >

Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app

The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

READ MORE >
physician acceptance of generative AI
Share on Twitter Share on Facebook Share on Linkedin

Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app

Share on Twitter Share on Facebook Share on Linkedin
physician acceptance of generative AI
The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.
READ MORE >

ASNC and AMA push back against AI prior authorization denials

Suman Tandon, MD, a representative of the American Society of Nuclear Cardiology, explains her organization's concerns about artificial intelligence being used to automatically deny prior authorizations and prevent patients from accessing care.

READ MORE >
Suman Tandon, MD, FASNC, a cardiac imager at St. Francis Hospital and Heart Center, in Rosyln, New York, and an American Society of Nuclear Cardiology (ASNC) representative to the American Medical Association (AMA) House of Delegates (HOD), explains ASNC's concerns about artificial intelligence being used to automatically deny prior authorizations and prevent patients from accessing care.
Share on Twitter Share on Facebook Share on Linkedin

ASNC and AMA push back against AI prior authorization denials

Share on Twitter Share on Facebook Share on Linkedin
Suman Tandon, MD, FASNC, a cardiac imager at St. Francis Hospital and Heart Center, in Rosyln, New York, and an American Society of Nuclear Cardiology (ASNC) representative to the American Medical Association (AMA) House of Delegates (HOD), explains ASNC's concerns about artificial intelligence being used to automatically deny prior authorizations and prevent patients from accessing care.
Suman Tandon, MD, a representative of the American Society of Nuclear Cardiology, explains her organization's concerns about artificial intelligence being used to automatically deny prior authorizations and prevent patients from accessing care.
READ MORE >

In Other News

Healthcare AI today: HL7 Int’l opens AI office, Justice Dept. uses AI, epidemiologist harbors AI skepticism, more

HL7 International is open for AI business. The interoperability organization announced the launch of its new AI office July 8.

READ MORE >
artificial intelligence AI healthcare HL7 FHIR
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI today: HL7 Int’l opens AI office, Justice Dept. uses AI, epidemiologist harbors AI skepticism, more

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI healthcare HL7 FHIR
HL7 International is open for AI business. The interoperability organization announced the launch of its new AI office July 8.
READ MORE >

AI in the ICU: ‘Unique challenges requiring specialized oversight’

The AI revolution in healthcare is less about technological advancement than change management vis-à-vis human relations. This may be nowhere more true than in critical care. 

READ MORE >
artificial intelligence in critical care ICU
Share on Twitter Share on Facebook Share on Linkedin

AI in the ICU: ‘Unique challenges requiring specialized oversight’

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence in critical care ICU
The AI revolution in healthcare is less about technological advancement than change management vis-à-vis human relations. This may be nowhere more true than in critical care. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: TAVR or SAVR? | Key trends in cardiac CT | Fraud allegations lead to $6.7M settlement | CTO PCI
FDA clears intravascular imaging tech | Key trends in cardiac CT | Heartflow sues rival | Opportunistic screening
Vascular specialist agrees to pay $6.7M | Robotic heart surgery: Worth the cost? | E-cigarette concerns | Heart tech on display
FDA clears next-gen heart device | Catching up with SCAI's new president | A warning for cath labs | Late-breaking PCI data
New data confirm long-term durability of Resilia tissue | CCTA delivers clarity, better outcomes | Cannabis use & heart attacks
TAVR Highlights: Predicting long-term outcomes | SCAI, ACC & STS share a message | Weight loss drug linked to key benefits
TAVR or SAVR? A closer look at those decisions | New Impella 5.5 data | First patient enrolled in massive heart failure trial

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …3
    • Page 4
    • Page 5
    • Page 6
    • Current page 7
    • Page 8
    • Page 9
    • Page 10
    • Page 11 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup